TABLE 2.
Subgroup analysis for the prevalence of depression among caregivers of cancer patients
| Subgroups | No. of studies | Prevalence (%) | 95% CI | Heterogeneity within the study (I 2 statistics (%)) |
|---|---|---|---|---|
| Types of tools used to assess depression | ||||
| BDI | 4 | 65.3 | 58.5–72.0 | 63.7 |
| CES‐D | 19 | 42.5 | 31.9–53.09 | 97.8 |
| HADS‐D | 8 | 34.4 | 21.0–47.8 | 99.5 |
| IDPESQ | 1 | 19 | 13.7–24.3 | 0.00 |
| DSM‐IV | 1 | 5 | 1.98–8.02 | 0.00 |
| DASS‐21 | 1 | 82 | 79.4–84.5 | 0.00 |
| HAM‐D | 1 | 53% | 48.0–47.9 | 0.00 |
| Study design used | ||||
| Cross‐sectional | 28 | 42.2 | 33.8–54.6 | 99.4 |
| Longitudinal | 7 | 33.6 | 17.7–49.6 | 98.7 |
| Gender of study participants | ||||
| Male | 4 | 34.4 | 12.4–66.1 | 97.4 |
| Female | 4 | 57.6 | 29.5–81.5 | 90.03 |
| Stage of cancer | ||||
| Terminal stage (stage 3 and 4) | 12 | 38.64 | 27.67–49.62 | 98.97 |
| Others | 23 | 43.82 | 34.10–53.54 | 98.93 |